New Shot Against Newborns' Severe RSV has 80% Efficiency, But May Not Be Available This 2023 Due to Insurance Loophole
A new shot against newborns' severe RSV may not be available this 2023 despite being 80% efficient. Here's why.
Source: hngn.com